Bloodpril vs Prescribed Medication: The Comparison Nobody Should Need
This article exists because the question gets asked, silently, by a lot of people buying products like this. It deserves a direct answer rather than a disclaimer.
Antihypertensive medication prevents strokes and heart attacks in trials with tens of thousands of participants. No supplement has ever demonstrated that.
What the medications have demonstrated
This is not a close comparison, and it is worth being specific about why.
Antihypertensive drug classes — ACE inhibitors, ARBs, calcium channel blockers, thiazide diuretics — have been tested in randomised outcome trials enrolling tens of thousands of participants and followed for years. The endpoints were not blood pressure readings. They were strokes, heart attacks, heart failure and death.
Those trials showed meaningful reductions in all of them. That is why these medicines are prescribed, and why guidelines are as specific as they are.
What supplements have demonstrated
Modest changes in blood pressure readings, in small trials, over weeks to months, at doses far above what most products supply.
No supplement has demonstrated a reduction in strokes or heart attacks. Not because the trials failed — because they have not been done, and doing them would require thousands of participants and years of follow-up that nobody in this industry funds.
So the comparison is not “medication versus supplement, which lowers pressure more.” It is “an intervention proven to prevent strokes versus an intervention that has never been tested for that at all.”
Compare Bloodpril packages and discount pricing
The two-bottle package is a 60-day supply against a 60-day guarantee — the only option whose full cost stays inside your refund window.
See Bloodpril pricingAffiliate link. We may earn a commission at no additional cost to you. Verified 2026-08-22.
What this means in practice
Never stop or reduce prescribed antihypertensive medication because a supplement seems to be working. This is the single most important sentence on this website, and the reason is worth understanding rather than just obeying.
Hypertension is symptomless. If your readings improve on medication, that is the medication working — it is the number with treatment, not the number you would have without it. Stopping does not preserve the improvement; it removes the cause of it.
Wanting to reduce medication is completely reasonable, and often achievable through weight loss, sodium reduction and activity. That is a monitored conversation with your prescriber, supported by the home readings you have been keeping. Bring the numbers. They genuinely help.
To its credit, the seller states this too: the product is described as not a replacement for prescribed cardiovascular treatment, and buyers are advised to consult their physician.
The mechanism is real — that is not the question
It is worth being precise about what is and is not in dispute here, because a lot of supplement criticism attacks mechanisms that are perfectly sound.
Nitric oxide signalling in the cardiovascular system earned the 1998 Nobel Prize in Physiology or Medicine. Endothelial nitric oxide synthase converts L-arginine into nitric oxide. Nitric oxide diffuses into vascular smooth muscle, activates guanylate cyclase, raises cGMP and relaxes the vessel. Widened vessels lower peripheral resistance, and lower resistance lowers blood pressure. Every step of that is textbook physiology.
Endothelial nitric oxide production genuinely does decline with age, and these genuinely are the right amino acids to target it. The seller describes all of this accurately — more accurately than most pages in this category.
The question is only ever how much. A correct mechanism supplied below its effective range is still a correct mechanism. It is just not a working product.
Independent background reading, none of it selling anything: the FDA dietary supplement overview, NIH Office of Dietary Supplements and MedlinePlus on preventing high blood pressure. For the applied version of this on our own pages, see the full ingredient breakdown and interaction table or the Bloodpril official website reference.
What we would do
Take the ingredient list to a pharmacist before ordering if you take anything cardiovascular, and to a cardiologist if you have had a heart attack. Buy a validated upper-arm monitor and record twice-daily readings for a fortnight before your first capsule so you have a baseline rather than an impression. Choose the two-bottle package, since 60 days of product against a 60-day guarantee is the only combination that keeps your whole spend inside the refund window. Diarise day 50 on the day you order.
Frequently asked
A 500 mg proprietary amino acid blend of L-Arginine HCL, L-Arginine Alpha-Ketoglutarate and L-Citrulline Malate, plus gelatin, rice flour and magnesium stearate as non-actives. Two capsules daily, 60 per bottle.
The blend total is — 500 mg per serving, which is more than most competitors publish. The split between the three amino acids is not.
L-arginine blood pressure trials used 6,000–12,000 mg daily and L-citrulline trials used 3,000–6,000 mg. A 500 mg blend is roughly 3–6% of that combined range.
Two bottles $158 ($79 each) plus $9.99 shipping, three bottles $207 ($69 each) with free US shipping and six bonus guides, or six bottles $294 ($49 each) with the same extras.
Disclaimer. This formula acts on the nitric oxide pathway — the same pathway as nitrate medicines such as nitroglycerin and isosorbide, and as PDE5 inhibitors such as sildenafil. Take the ingredient list to a pharmacist before ordering if you take any cardiovascular medication, and to a cardiologist if you have had a heart attack. Never stop or reduce prescribed blood pressure medication to take a supplement. These statements have not been evaluated by the Food and Drug Administration, and Bloodpril is not intended to diagnose, treat, cure or prevent any disease.
Affiliate disclosure. This page contains affiliate links. We may earn a commission if you purchase through them, at no additional cost to you. That does not change what we publish — see our full disclosure.